Abstract
The in vitro activity of coumermycin A1 was compared with that of novobiocin, ampicillin, and minocycline. Coumermycin was found to be the most active antibiotic of the four against Staphylococcus aureus. It was about 50 times more active than novobiocin or minocycline against the strains tested. Coumermycin also showed good activity against group A streptococci and pneumococci, moderate activity against Escherichia coli, indole-positive Proteus species, and Pseudomonas aeruginosa, and poor activity against Klebsiella-Enterobacter and enterococci. Against P. mirabilis, however, coumermycin activity was almost equal to that of ampicillin. The new antibiotic was further found to be greatly reduced in activity in the presence of plasma, but its minimal inhibitory concentration was not greatly affected by inoculum size. Coumermycin was found to be bacteriostatic in its action, and resistance to it developed slowly. Also, cross-resistance was present with novobiocin but absent with ampicillin or minocycline.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berger J., Schocher A. J., Batcho A. D., Pecherer B., Keller O., Maricq J., Karr A. E., Vaterlaus B. P., Furlenmeier A., Speigelberg H. Production, isolation, and synthesis of the coumermycins (sugordomycins), a new streptomycete antibiotic complex. Antimicrob Agents Chemother (Bethesda) 1965;5:778–785. [PubMed] [Google Scholar]
- Fedorko J., Katz S., Allnoch H. In vitro activity of minocycline, a new tetracycline. Am J Med Sci. 1968 Apr;255:252–258. doi: 10.1097/00000441-196804000-00006. [DOI] [PubMed] [Google Scholar]
- Grunberg E., Bennett M. Chemotherapeutic properties of coumermycin A1. Antimicrob Agents Chemother (Bethesda) 1965;5:786–788. [PubMed] [Google Scholar]
- Grunberg E., Cleeland R., Titsworth E. Further observations on chemotherapeutic activity of coumermycin A1. I. Activity against Neisseria meningitidis type A and meningopneumonitis. Antimicrob Agents Chemother (Bethesda) 1966;6:397–398. doi: 10.1128/AAC.6.4.397. [DOI] [PubMed] [Google Scholar]
- Hoeprich P. D. Susceptibility of staphylococci to new antimicrobial agents. Antimicrob Agents Chemother (Bethesda) 1967;7:697–704. [PubMed] [Google Scholar]
- KAWAGUCHI H., NAITO T., TSUKIURA H. STUDIES ON COUMERMYCIN. A NEW ANTIBIOTIC. II. STRUCTURE OF COUMERMYCIN A1. J Antibiot (Tokyo) 1965 Jan;18:11–25. [PubMed] [Google Scholar]
- KAWAGUCHI H., TSUKIURA H., OKANISHI M., MIYAKI T., OHMORI T., FUJISAWA K., KOSHIYAMA H. STUDIES ON COUMERMYCIN, A NEW ANTIBIOTIC. I. PRODUCTION, ISOLATION AND CHARACTERIZATION OF COUMERMYCIN A1. J Antibiot (Tokyo) 1965 Jan;18:1–10. [PubMed] [Google Scholar]
- Keil J. G., Hooper I. R., Cron M. J., Farbig O. B., Nettleton D. E. Semisynthetic coumermycins. I. Preparation of 3-acylamido-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl)noviosyloxy]coumarins. J Antibiot (Tokyo) 1968 Sep;21(9):551–566. [PubMed] [Google Scholar]